Physician

Ananda Reddy Gurram, M.D.

According to 2025 Medicare claims, Ananda Gurram, M.D. (NPI: 1427287267) practices nephrology in the Fayetteville, NC market, with the plurality of this provider's patient population coming from Cumberland, NC. This provider's primary affiliated billing organization is CAROLINA KIDNEY CARE, PA (NPI: 1831198761; TIN: 56-1782802) and primary practice location at 28301-4912.

Gurram's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 472 traditional Medicare patients, billed 1,573 HCPCS/CPT codes, and received $197,858 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 738 prescription claims across 159 beneficiaries totaling $364,663 in drug costs, led by Tavneos (Avacopan). 2015 DME data shows 56 claims. Open Payments data shows 19 records totaling $359. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $9,486 and ending at $364,663. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	447	1,526	$94,057
2016	735	3,520	$231,844
2017	685	4,892	$215,846
2018	645	3,425	$190,829
2019	738	2,928	$296,489
2020	535	2,664	$394,697
2021	405	1,611	$304,242
2022	458	1,608	$257,913
2023	501	1,412	$207,252
2024	472	1,573	$197,858

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	70	259	$9,486
2016	69	311	$94,394
2017	80	524	$877,377
2018	91	498	$717,851
2019	90	396	$413,702
2020	92	492	$114,992
2021	118	592	$149,825
2022	115	516	$108,167
2023	141	594	$219,426
2024	159	738	$364,663

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	56	$7,332
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	73	117	$130
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	77	82	$93
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	154	164	$87
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	113	330	$59
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	206	250	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tavneos	Avacopan	11	330	$154,626
Velphoro	Sucroferric Oxyhydroxide	18	780	$46,025
Veltassa	Patiromer Calcium Sorbitex	16	574	$20,175
Jardiance	Empagliflozin	15	810	$16,076
Farxiga	Dapagliflozin Propanediol	20	690	$11,772

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	19	$359	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ananda Reddy Gurram, M.D.?

Tedicare shows public-source Medicare data for Ananda Reddy Gurram, M.D. (NPI 1427287267), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ananda Reddy Gurram, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ananda Reddy Gurram, M.D.?

Ananda Reddy Gurram, M.D. is linked to CAROLINA KIDNEY CARE, PA (billing NPI 1831198761) in the available physician profile data.

Does Ananda Reddy Gurram, M.D. have Open Payments data?

Ananda Reddy Gurram, M.D. has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.